Zobrazeno 1 - 10
of 103
pro vyhledávání: ''
Autor:
Miguel Martín, Laia Paré, Barbara Adamo, Roberta Fasani, Blanca Gonzalez-Farre, Benedetta Conte, Giovanna Sabarese, Carlos H. Barrios, Fara Brasó-Maristany, Esther Sanfeliu, Mariavittoria Locci, Giuseppe Perrone, Francesca Zalfa, Esther Barnadas, Olga Martínez-Sáez, Aranzazu Fernandez-Martinez, Ana Lluch, Maria Vidal, Joaquín Gavilá, Tomás Pascual, Aleix Prat, Francesco Schettini, Sabino De Placido, Patricia Villagrasa, Vicente Peg, Nuria Chic, Juan Miguel Cejalvo
Publikováno v:
Dipòsit Digital de la UB
Universidad de Barcelona
Scientia
NPJ Breast Cancer
npj Breast Cancer, Vol 7, Iss 1, Pp 1-13 (2021)
Universidad de Barcelona
Scientia
NPJ Breast Cancer
npj Breast Cancer, Vol 7, Iss 1, Pp 1-13 (2021)
Càncer de mama; Genòmica del càncer; Recerca translacional Cáncer de mama; Genómica del cáncer; Investigación traslacional Breast cancer; Cancer genomics; Translational research Novel antibody-drug conjugates against HER2 are showing high acti
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5c10b99479fa39b069aa421ecf890520
http://hdl.handle.net/2445/175264
http://hdl.handle.net/2445/175264
Publikováno v:
Breast Cancer Research and Treatment
Purpose This systematic review examined educational training interventions for healthcare professionals (HCPs) discussing genetic testing and risk for hereditary breast cancer. There was a particular focus on the presence, and content, of communicati
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c95c00137135ccdad16368a0165e339f
http://sro.sussex.ac.uk/id/eprint/92115/1/Starkings_et_al-2020-Breast_Cancer_Research_and_Treatment.pdf
http://sro.sussex.ac.uk/id/eprint/92115/1/Starkings_et_al-2020-Breast_Cancer_Research_and_Treatment.pdf
Autor:
Jon Emery, Cristina Renzi, Georgios Lyratzopoulos, Greg Rubin, Willie Hamilton, Niek J. de Wit, Fiona M Walter, Hardeep Singh, Richard D Neal, Aradhna Kaushal, Bernard Rachet
Publikováno v:
Nature Reviews Clinical Oncology, 16(12), 746. Nature Publishing Group
An earlier diagnosis is a key strategy for improving the outcomes of patients with cancer. However, achieving this goal can be challenging, particularly for the growing number of people with one or more chronic conditions (comorbidity/multimorbidity)
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3b7eae9ffd1b6337625278ba256d6a47
Autor:
Masako Sato, Hidetoshi Kawaguchi, Satoshi Morita, Makiko Mizutani, Yoshie Hasegawa, Ken-ichi Watanabe, Yasuaki Sagara, Fumikata Hara, Takashi Morimoto, Takahiro Nakayama, Norikazu Masuda, Mitsuya Itoh, Shoichiro Ohtani, Nobuki Matsunami, Kenji Higaki, Masato Takahashi, Tetsuhiro Yoshinami
Publikováno v:
Breast Cancer (Tokyo, Japan)
Background This study aimed to investigate whether schedule modification is safe and effective in patients intolerant to the standard eribulin dose and schedule. Methods Patients with metastatic breast cancer (MBC) treated with both anthracycline and
Autor:
Hisashi Motomura, Wataru Goto, Shinichiro Kashiwagi, Yuka Asano, Shuhei Tomita, Koji Takada, Masahiko Ohsawa, Katsuyuki Takahashi, Kosei Hirakawa, Masaichi Ohira, Tsutomu Takashima, Takaharu Hatano
Publikováno v:
British Journal of Cancer
Background Immune responses in a tumour microenvironment can be evaluated by analysing tumour-infiltrating lymphocyte (TIL) density; this has been verified in the clinical setting. Although there are many reports on TIL density in primary tumours, li
Autor:
Michael S. Toss, Emad A. Rakha, Chitra Joseph, Padmashree C.G. Rida, Andrew R. Green, Ian O. Ellis, Nigel P. Mongan, Mohammed A. Aleskandarany, Ibrahim Alshankyty, Mansour Alsaleem, Sasagu Kurozumi, Angela Ogden, Ritu Aneja
E-cadherin is a tumor suppressor gene in invasive lobular breast cancer. However, a proportion of high-grade ductal carcinoma shows reduced/loss of E-cadherin. In this study, we assessed the underlying mechanisms and molecular implications of E-cadhe
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::7a4fd096ae4d5a4d6360edf9b34a9f20
https://clok.uclan.ac.uk/34530/1/34530.pdf
https://clok.uclan.ac.uk/34530/1/34530.pdf
Autor:
M. Bellet Ezquerra, S. Antolin Novoa, Mafalda Oliveira, E. Martínez de Dueñas, S. López-Tarruella Cobo, M. A. Segui Palmer, L. de la Cruz Merino, J. Gavila Gregori, I. Álvarez López, J. I. Chacón López-Muñiz
Publikováno v:
Digital.CSIC. Repositorio Institucional del CSIC
instname
Scientia
Recercat: Dipósit de la Recerca de Catalunya
Varias* (Consorci de Biblioteques Universitáries de Catalunya, Centre de Serveis Científics i Acadèmics de Catalunya)
Recercat. Dipósit de la Recerca de Catalunya
Clinical & Translational Oncology
instname
Scientia
Recercat: Dipósit de la Recerca de Catalunya
Varias* (Consorci de Biblioteques Universitáries de Catalunya, Centre de Serveis Científics i Acadèmics de Catalunya)
Recercat. Dipósit de la Recerca de Catalunya
Clinical & Translational Oncology
Recurrència loco-regional; Càncer de mama; Pautes Recurrencia loco-regional; Cáncer de mama; Pautas Loco-regional recurrence; Breast cancer; Guidelines Although the metastasic breast cancer is still an incurable disease, recent advances have incre
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c99ab8f97d50d5114bc5b368698614ee
http://hdl.handle.net/10261/212722
http://hdl.handle.net/10261/212722
Autor:
Judy Garber, Clara Li, Kevin S. Hughes, Suzanne B. Coopey, Francisco Acevedo, Amy S. Colwell, Danielle Braun, Regina Barzilay, Adam Yala, Tari A. King, Barbara L. Smith, Anthony J. Guidi, Curtis L. Cetrulo, Rong Tang, V. Diego Armengol, Zhengyi Deng
Publikováno v:
Other repository
© 2018, Springer Science+Business Media, LLC, part of Springer Nature. Purpose: Mammoplasty removes random samples of breast tissue from asymptomatic women providing a unique method for evaluating background prevalence of breast pathology in normal
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::18e84cacd853968a680255161596c752
https://hdl.handle.net/1721.1/134753
https://hdl.handle.net/1721.1/134753
Autor:
Zsuzsanna Varga, Thomas Ruhstaller, Ulrike Perriard, Dirk Klingbiel, Tilman T. Rau, Jean-Christophe Tille, Beat Thuerlimann, Hanne Hawle, Qiyu Li, Wolfram Jochum
Publikováno v:
Varga, Zsuzsanna; Li, Qiyu; Jochum, Wolfram; Perriard, Ulrike; Rau, Tilman; Tille, Jean-Christoph; Hawle, Hanne; Klingbiel, Dirk; Thuerlimann, Beat; Ruhstaller, Thomas (2019). Ki-67 assessment in early breast cancer: SAKK28/12 validation study on the IBCSG VIII and IBCSG IX cohort. Scientific reports, 9(1), p. 13534. Springer Nature 10.1038/s41598-019-49638-4
Scientific Reports, Vol 9, Iss 1, Pp 1-11 (2019)
Scientific Reports, Vol. 9, No 1 (2019) P. 13534
Scientific Reports
Scientific Reports, Vol 9, Iss 1, Pp 1-11 (2019)
Scientific Reports, Vol. 9, No 1 (2019) P. 13534
Scientific Reports
The assessment of Ki-67 in early-stage breast cancer has become an important diagnostic tool in planning adjuvant therapy, particularly for the administration of additional chemotherapy to hormone-responsive patients. An accurate determination of the
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::509ed0eb6c511bb431eb561f8c240921
Autor:
Arja Jukkola-Vuorinen, Anniina Jääskeläinen, Kirsi-Maria Haapasaari, Päivi Auvinen, Ylermi Soini, Peeter Karihtala
Publikováno v:
BMC Cancer
BMC Cancer, Vol 18, Iss 1, Pp 1-10 (2018)
BMC Cancer, Vol 18, Iss 1, Pp 1-10 (2018)
Background: The subtype of claudin-low breast cancer can be reliably determined only by gene-expression profiling. Attempts have been made to develop immunohistochemical surrogates, which nearly always focus on membranous claudin expression. Methods:
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0882fc6ea4b5d717997d116945eea4b4
http://urn.fi/urn:nbn:fi-fe201804196713
http://urn.fi/urn:nbn:fi-fe201804196713